Nina Shah Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

10/2020	Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
1/2018	Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
1/2018	ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
11/2016	Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
5/2015	Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
2/2015	Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo.
1/2014	Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment.
1/2014	Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.
10/2013	A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nina Shah Research Topics

Disease

85	Multiple Myeloma 05/2024 - 01/2012
25	Neoplasms (Cancer) 04/2024 - 09/2007
15	Hematologic Neoplasms (Hematological Malignancy) 07/2023 - 12/2014
9	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020 - 10/2013
8	Infections 01/2023 - 02/2002
5	Residual Neoplasm 05/2024 - 02/2017
5	Plasma Cell Leukemia 07/2022 - 01/2019
4	Cytokine Release Syndrome 01/2023 - 01/2021
4	Lymphoma (Lymphomas) 01/2017 - 01/2012
3	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2012
3	Pain (Aches) 01/2022 - 02/2005
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 09/2010
3	Fever (Fevers) 01/2021 - 01/2002
3	Disease Progression 11/2019 - 10/2013
3	Mucositis 05/2019 - 01/2016
3	Hodgkin Disease (Hodgkin's Disease) 01/2016 - 11/2012
3	Inflammation (Inflammations) 02/2015 - 02/2005
2	Chromosome Aberrations (Chromosome Abnormalities) 04/2024 - 11/2015
2	cell-associated neurotoxicity 01/2023 - 01/2021
2	Pneumonia (Pneumonitis) 01/2020 - 01/2002
2	Dermatitis 06/2017 - 01/2016
2	Pure Red-Cell Aplasia 05/2016 - 03/2013
2	Amyloidosis 02/2016 - 01/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2014 - 06/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2014 - 06/2014
2	Body Weight (Weight, Body) 04/2014 - 12/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2012 - 01/2012
2	HIV Infections (HIV Infection) 05/2006 - 02/2002
2	Anemia 02/2002 - 01/2002
2	Oral Candidiasis (Thrush) 02/2002 - 01/2002
1	Toxoplasmosis 02/2024
1	Lung Neoplasms (Lung Cancer) 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023
1	Poisoning 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023
1	Sudden Infant Death (SID) 01/2023
1	Acidosis 01/2023
1	Cytopenia 01/2023
1	Delirium 01/2023
1	Bone Marrow Diseases (Bone Marrow Disease) 01/2023
1	Hypersensitivity (Allergy) 12/2022
1	Injection Site Reaction 12/2022
1	Neutropenia 12/2022

Drug/Important Bio-Agent (IBA)

21	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2019
15	Lenalidomide (CC 5013)FDA Link 05/2024 - 06/2014
12	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 01/2012
11	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2024 - 01/2020
11	B-Cell Maturation AntigenIBA 03/2024 - 01/2020
10	daratumumabIBA 04/2024 - 01/2020
8	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 01/2019
8	Bortezomib (Velcade)FDA Link 04/2024 - 05/2012
8	Busulfan (Busulfex)FDA Link 05/2019 - 11/2012
7	idecabtagene vicleucelIBA 01/2023 - 01/2021
6	trans-crotonin (CTN)IBA 12/2023 - 01/2019
6	Proteasome InhibitorsIBA 01/2023 - 09/2017
5	Monoclonal AntibodiesIBA 01/2023 - 01/2020
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 03/2013
3	VaccinesIBA 12/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2020
3	Rituximab (Mabthera)FDA Link 09/2021 - 11/2015
3	carfilzomibIBA 01/2021 - 01/2020
3	AntigensIBA 01/2020 - 07/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2016
3	fludarabineIBA 01/2019 - 10/2013
3	Gemcitabine FDA Link 06/2017 - 11/2012
2	venetoclaxIBA 07/2022 - 01/2020
2	MethyltransferasesIBA 01/2020 - 01/2016
2	Immunomodulating AgentsIBA 01/2020 - 09/2017
2	FM 100 (FM100)IBA 01/2019 - 10/2013
2	SteroidsIBA 01/2018 - 04/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 11/2016 - 03/2013
2	Amyloid (Amyloid Fibrils)IBA 02/2016 - 01/2012
2	Vorinostat FDA Link 01/2016 - 11/2015
2	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2006 - 02/2005
2	Zidovudine (Retrovir)FDA LinkGeneric 02/2002 - 01/2002
1	Adenosine Monophosphate (AMP)IBA 04/2024
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023
1	pembrolizumabIBA 11/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023
1	AnionsIBA 01/2023
1	Methanol (Carbinol)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Fomepizole (Antizol)FDA LinkGeneric 01/2023
1	lysine(6)- glutaryl- 2- (hydroxymethyl)anthraquinone LHRH (T 98)IBA 12/2022

Therapy/Procedure

57	Therapeutics 04/2024 - 05/2003
20	Cell Transplantation 05/2024 - 03/2013
20	Hematopoietic Stem Cell Transplantation 02/2024 - 03/2012
20	Transplantation 10/2023 - 11/2012
17	Drug Therapy (Chemotherapy) 03/2022 - 07/2012
15	Stem Cell Transplantation 10/2023 - 09/2010
6	Autologous Transplantation 01/2023 - 01/2018
5	Immunotherapy 01/2021 - 06/2015
2	Salvage Therapy 03/2024 - 01/2022
2	Blood Component Removal (Apheresis) 01/2017 - 07/2011
1	Retreatment 03/2024
1	Palliative Care (Palliative Therapy) 07/2023
1	Renal Dialysis (Hemodialysis) 01/2023
1	Hematopoietic Stem Cell Mobilization 01/2023